Life Extension Final Clerance Sale

Prostate Cancer Prevention

References

Abdull Razis AF, Noor NM. Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pac J Cancer Prev. 2013;14(3):1565-70. 

Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70.

Abrahamsson PA, Lilja H, Oesterling JE. Molecular forms of serum prostate-specific antigen. The clinical value of per­cent free prostate-specific antigen. Urol Clin North Am. 1997 May;24(2):353-65.

ACS. American Cancer Society. Imaging (Radiology) Tests. Nuclear Scans. Available at: http://www.cancer.org/treatment/understandingyourdiagnosis/examsandtestdescriptions/imagingradiologytests/imaging-radiology-tests-nuc-scan. Last updated 8/9/2013a. Accessed 10/25/2013.

ACS. American Cancer Society. Inositol Hexaphosphate. Find Support & Treatment page. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/dietandnutrition/inositol-hexaphosphate. Last updated 8/5/2013b. Accessed 10/21/2013.

ACS. American Cancer Society. Learn About Cancer page. Prostate Cancer. Early Detection, Diagnosis, and Staging Topics. How is prostate cancer diagnosed? http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-diagnosis. Last updated 8/26/2013c. Accessed 10/24/2013.

ACS. American Cancer Society. Modified Citrus Pectin. Find Support & Treatment page. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/dietandnutrition/modified-citrus-pectin. Last updated 11/1/2008. Accessed 10/21/2013.

ACS. American Cancer Society. Prostate Cancer. What are the key statistics about prostate cancer? Available at: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics. Last updated 8/26/2013d. Accessed 10/28/2013.

ACS. American Cancer Society. Prostate Cancer. What are the key statistics about prostate cancer? Available at: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics. Last updated 8/26/2013e. Accessed 10/18/2013.

Adan Y, Shibata K, Sato M, Ikeda I, Imaizumi K. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci Biotechnol Biochem. 1999 Jan;63(1):111-9. 

Adhami VM, Khan N, Mukhtar H. Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer. 2009;61(6):811-5. 

Adhami VM, Siddiqui IA, Syed DN, Lall RK, Mukhtar H. Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. Carcinogenesis. 2012 Mar;33(3):644-51. 

Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treat­ment for prostate cancer. J Urol. 2005 Feb;173(2):533-6.

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004 Sep- Oct;24(5A):2783-840. 

Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75. 

Aggarwal BB, Yuan W, Li S, Gupta SC. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Mol Nutr Food Res. 2013 Jul 12. 

Ahmed S, Rahman A, Hasnain A, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med. 2002 Oct 15;33(8):1097-105. 

AHRQ. Agency for Healthcare Research and Quality. Screening and Risk Assessment for Osteoporosis in Postmenopausal Women. Comparison of Recommendations: Measurement of BMD: Modality and Frequency. Available at: http://www.medscape.com/viewarticle/738733_5. 3/16/2011. Accessed 10/25/2013.

Albertsen K, Gronbaek M. Does amount or type of alcohol influence the risk of prostate cancer? Prostate. 2002;52:297-304. 

Albrecht M, Jiang W, Kumi-Diaka J, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food. 2004 Fall;7(3):274-83. 

Allard CB, Dason S, Lusis J, Kapoor A. Prostate cancer screening: Attitudes and practices of family physicians in Ontario. Can Urol Assoc J. 2012 6(3):188-93.

Ammon HP. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien Med Wochenschr. 2002 152(15-16):373-8. 

Anderson KM, Seed T, Vos M et al. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death. Prostate. 1998 Nov 1;37(3):161-73. 

Andriole G, Bruchovsky N, Chung LW, et al. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 2004 Oct;172(4 Pt 1):1399-403.

Andriole GL, Bostwick DG, Brawley OW, et al; REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 1;362(13):1192-202.

Andriole GL, Marberger M, Roehrborn CG. Clinical usefulness of serum prostate spe­cific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutaste­ride. J Urol. 2006 May;175(5):1657-62.

Angelucci A, Garofalo S, Speca S, et al. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells. Endocr Relat Cancer. 2008 Mar;15(1):91-100. 

Anisimov VN, Berstein LM, Egormin PA, et al. Effect of metformin on life span and on the development of spontane­ous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol. 2005 Aug-Sep;40(8-9):685-93.

Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax); A novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9. 

Arena F. Specific antigen prostatic changes during treatment with finasteride or dutas­teride for benign prostatic hyperplasia. Mi­nerva Urol Nefrol. 2013 Sep;65(3):211-216.

Arnaldez FI, Helman LJ. Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am. 2012 Jun;26(3):527- 42,vii-viii.

AUA. American Urological Association. AUA Releases New Clinical Guideline on Prostate Cancer Screening. Available at: http://www.auanet.org/advnews/press_releases/article.cfm?articleNo=290. 5/3/2013. Accessed 10/28/2013.

Aune D, De Stefani E, Ronco AL, et al. Egg consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009;10(5):869-76. 

Avci CB, Harman E, Dodurga Y, Susluer SY, Gunduz C. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765-8.

Awad AB, Burr AT, Fink CS. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids. 2005 Mar;72(3):219-26. 

Awad AB, Fink CS, Williams H, Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev. 2001 Dec;10(6):507-13. 

Baek SJ, Wilson LC, Eling TE. Resveratrol enhances the expression of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis. 2002 Mar;23(3):425-34. 

Barham JB, Edens MB, Fonteh AN, et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000 Aug;130(8):1925-31. 

Barranco WT, Eckhert CD. Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett. 2004 Dec 8;216(1):21-9. 

Barve A, Khor TO, Nair S, et al. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer. 2009 Apr 1;124(7):1693-9.

Bastian PJ, Boorjian SA, Bossi A, et al. High-risk prostate cancer: from definition to contemporary management. Eur Urol. 2012 Jun;61(6):1096-106.

Bataineh ZM, Hani IH Bani, Al-Alami JR. Zinc in normal and pathological human prostate gland. Saudi Med Jour. 2002;23(2):218-20. 

Beaver LM, Yu TW, Sokolowski EI, Williams DE, Dashwood RH, Ho E. 3,3’-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol Appl Pharmacol. 2012 Sep 15;263(3):345-51. 

Bemis DL, Capodice JL, Anastasiadis AG, Katz AE, Buttyan R. Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 ex­pression. Nutr Cancer. 2005 52(2):202-12.

Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. On­cogene. 2008 Jun 5;27(25):3576-86.

Ben Sahra I, Regazzetti C, Robert G, et al. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 2011 Jul 1;71(13):4366-72.

Benchikh El Fegoun A, Villers A, Moreau JL, Richaud P, Rebillard X, Beuzeboc P. PSA and follow-up after treatment of prostate cancer. Prog Urol. 2008 Mar;18(3):137-44. 

Bengmark S. Curcumin, an atoxic antioxi­dant and natural NFkappaB, cyclooxygen­ase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Par­enter Enteral Nutr. 2006 Jan;30(1):45-51.

Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological upgrading and up staging with im­mediate repeat biopsy in patients eligible for active surveillance. J Urol. 2008 Nov;180(5):1964-7.

Bergman Jungeström M, Thompson LU, Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res. 2007 Feb 1;13(3):1061-7. 

Berquin IM, Min Y, Wu R, et al. Modula­tion of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest. 2007 Jul;117(7):1866-75.

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006 Jan 15;66(2):1234-40. 

Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Ath­erosclerosis. 2009 Apr;203(2):489-93.

Bidoli E, Talamini R, Bosetti C, et al. Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol. 2005 Jan;16(1):152-7.

Billis A. Latent carcinoma and atypical lesions of prostate. An autopsy study. Urol­ogy. 1986 Oct;28(4):324-9.

Biri H, Ozturk HS, Kacmaz M, et al. Activities of DNA turnover and free radical metabolizing enzymes in cancerous human prostate tissue. Cancer Invest. 1999;17(5):314-9.

Bischoff SC. University of Hohenheim. Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2012 [cited 2013 Oct 21]. Available at: http://clinicaltrials.gov/show/NCT01538316. NLM Identifier: NCT01538316.

Bohnet HG, Hanker JP, Horowski R, Wick­ings EJ, Schneider HP. Suppression of pro­lactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinae­mic menstrual disorders. Acta Endocrinol (Copenh). 1979 Sep;92(1):8-19.

Bokhorst LP, Bangma CH, van Leenders GJ, et al. Prostate-specific antigen-based prostate cancer screening: Reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam Section of the European Randomized Study of Screening for Pros­tate Cancer. Eur Urol. Aug 11 2013.

Bolotin HH. Inaccuracies inherent in dual-energy X-ray absorpti­ometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antire­sorptive therapy effectiveness. Bone. 2001;28:548–55.

Bonkhoff H, Fixemer T. Implications of estrogens and their receptors for the development and progression of prostate cancer. Pathologe. 2005 Nov;26(6):461-8. 

Bonvissuto G, Minutoli L, Morgia G, et al. Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study. Urology. 2011 Jan;77(1):248.e9-16. 

Bosland MC. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann NY Acad Sci. 2006 Nov;1089:168-76.

Bostwick DG, Qian J, Civantos F, Roehrborn CG, Montironi R. Does finasteride alter the pathology of the prostate and cancer grading? Clin Prostate Cancer. 2004 Mar;2(4):228-35.

Brahmbhatt M, Gundala SR, Asif G, Shamsi SA, Aneja R. Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutr Cancer. 2013 Feb;65(2):263-72. 

Brasky TM, Kristal AR, Navarro SL, et al. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 2011;63(4):573-82. 

Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol. 2001 Dec;166(6):2034-8. 

Bul M, van den Bergh RC, Zhu X, et al. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer. BJU Int. 2012 Dec;110(11):1672-7. 

Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003 Apr;38(4):343-52.

Canene-Adams K, Lindshield BL, Wang S, Jeffery EH, Clinton SK, Erdman JW, Jr. Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res. 2007 Jan 15;67(2):836-43. 

Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecol Oncol. 2010 Jan;116(1):92-8.

Capodice JL, Gorroochurn P, Cammack AS, et al. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial. J Soc Integr Oncol. 2009 7(2):43-51.

Carlson RH. Prostate Cancer, Diabetes Link Points to Potential Treatment with Metformin. Oncology Times web page. Available at: http://journals.lww.com/oncology-times/blog/onlinefirst/pages/post.aspx?Postid=451. 4/22/2012. Accessed 10/29/2013.

Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem. 2007 Nov 1;102(4):899-911.

Carter HB, Partin AW, Walsh PC, et al. Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol. 2012 Dec 10;30(35):4294-6.

Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994 May;151(5):1283-90.

Catella-Lawson F. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. Neurology. 2001 57(5 Suppl 2):S5-S7. 

Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann NY Acad Sci. 2006 Nov;1089:286-301.

CDC. Centers for Disease Control and Prevention. HIV in the United States: At A Glance. Available at: http://www.cdc.gov/hiv/statistics/basics/ataglance.html. Last updated 4/23/2013a. Accessed 10/28/2013.

CDC. Centers for Disease Control and Prevention. Prostate Cancer Statistics. Available at: http://www.cdc.gov/cancer/prostate/statistics/. Last updated 10/23/2013b. Accessed 12/10/2013.

Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci E. Dairy prod­ucts, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr. 2001 74(4):549-554.

Chan R, Lok K, Woo J. Prostate cancer and vegetable consumption. Mol Nutr Food Res. 2009 Feb;53(2):201-16. 

Chao C, Haque R, Van Den Eeden SK, Caan BJ, Poon KY, et al. Red wine consumption and risk of prostate cancer: the California men’s health study. Int J Cancer. 2010;126:171-9. 

Chaudhary LR, Hruska KA. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem. 2003;89(1):1-5. 

Chen L, Davey Smith G, Evans DM, et al. Genetic variants in the vitamin d receptor are associated with advanced prostate can­cer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Bio­markers Prev. 2009 Nov;18(11):2874-81.

Chen LH, Fang J, Li H, Demark-Wahnefried W, Lin X. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther. 2007 Sep;6(9):2581-90. 

Chen LH, Fang J, Sun Z, Li H, Wu Y, Demark-Wahnefried W, Lin X. Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr. 2009 Apr;139(4):653-9. 

Chen Y, Zaman MS, Deng G, et al. Mi­croRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 2011 Jan;4(1):76-86.

Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 2004 Feb 26;23(8):1599-607. 

Cheng TS, Chen WC, Lin YY, et al. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res (Phila). 2013 May;6(5):495-505. 

Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002 Apr 19;296(5567):539-41. 

Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol. 2002 Mar;20(3):631-6. 

Chiao JW, Wu H, Ramaswamy G, et al. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis. 2004 Aug;25(8):1403-8. 

Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole- 3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001 May 24;20(23):2927-36. 

Chinnici CM, Yao Y, Pratico D. The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging. 2007 Sep;28(9):1457-62. 

Choi HY, Lim JE, Hong JH. Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells. Prostate Cancer Prostatic Dis. 2010 Dec;13(4):343-9.

Choi S, Singh SV. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res. 2005 Mar 1;65(5):2035-43. 

Choi YK, Park KG. Metabolic roles of AMPK and metformin in cancer cells. Mol Cells. 2013 Jun 19.

Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3217-22. 

Chu J, Pratico D. The 5-lipoxygenase as a common pathway for pathological brain and vascular aging. Cardiovasc Psychiatry Neurol. 2009;2009:174657. 

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol Nutr Food Res. 2011 Nov;55(11):1666-76. 

Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin- 3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett. 2009 Mar 8;275(1):86-92.

Clark LC, Combs GF, Jr., Turnbull BW. et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957-63. 

Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double- blind cancer prevention trial. Br J Urol. 1998 May;81(5):730-4. 

Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May;89(5):2179-84.

Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008 Oct 8;269(2):291-304. 

Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res. 2011 Jul;55(7):999-1009. 

Clements A, Gao B, Yeap SH, Wong MK, Ali SS, Gurney H. Metformin in prostate cancer: two for the price of one. Ann On­col. 2011 Dec;22(12):2556-60.

Cleveland Clinic. Heart and Vascular Health & Prevention. Cleveland Clinic web page. Available at: http://my.clevelandclinic.org/heart/prevention/nutrition/omega3.aspx. 9/2009. Accessed 10/21/2013.

Cohen YC, Liu KS, Heyden NL, et al. De­tection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Preven­tion Trial. J Natl Cancer Inst. 2007 Sep 19;99(18):1366-74.

Connors SK, Chornokur G, Kumar NB. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer. 2012;64(1):4-22. 

Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ. γ-Tocopherol detoxification of nitrogen dioxide: Superiority to α-tocopherol. Proc Natl Acad Sci USA. 1993;90(5):1771– 1775. 

Cox ME, Gleave ME, Zakikhani M, et al. Insulin receptor expression by human prostate cancers. Prostate. 2009 Jan 1;69(1):33-40.

Cui Y, Winton MI, Zhang ZF, et al. Dietary boron intake and prostate cancer risk. Oncol Rep. 2004 Apr;11(4):887-92. 

Currie CJ, Poole CD, Gale EA. The influ­ence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009 Sep;52(9):1766-77.

D’Amico A, Chen M, Roehl K, Catalona W. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351(2):125-35.

Dagvadorj A, Collins S, Jomain JB, et al. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription- 5a/b signaling pathway. Endocrinology. 2007 Jul;148(7):3089-101.

Dandona P, Rosenberg MT. A practical guide to male hypo­gonadism in the primary care setting. Int J Clin Pract. 2010 May;64(6):682-96.

Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007 Oct;17 (5):363-9. 

Dassesse T, de Leval X, de Leval L, Pirotte B, Castronovo V, Waltregny D. Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol. 2006 Nov;50(5):1021-31. 

Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer. 1999 35(2):167-74.

Davis JN, Singh B, Bhuiyan M, Sarkar FH. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer. 1998 32(3):123-31.

Davis-Searles PR, Nakanishi Y, Kim NC, et al. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res. 2005 May 15;65(10):4448-57. 

Day JR, Jost M, Reynolds MA, Groskopf J, Rittenhouse H. PCA3: from basic molecular science to the clinical lab. Cancer Lett. 2011 Feb 1;301(1):1-6.

de Leval X, Hanson J, David JL, et al. New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators. Curr Med Chem. 2004 May;11(10):1243-52. 

Deckelbaum RJ, Worgall TS, Seo T. n-3 fatty acids and gene expression. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1520S-1525S.

Demark-Wahnefried W, Polascik TJ, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87. 

Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, Vollmer RT. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004 May;63(5):900-4. 

Demer LL and Abedin M. Skeleton key to vascular disease. J Am Coll Cardiol. 2004;44(10):1977-1979.

Demer LL and Tintut Y. Osteopontin: Between a Rock and Hard Plaque. Circulation Research. 1999;84:250-252.

Dias VC, Parsons HG. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J Lipid Res. 1995 Mar;36(3):552-63. 

Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 1999 Jul 22;261(1):218-23. 

Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004 Oct 20;3:19. 

Dong X, Xu W, Sikes RA, Wu C. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chem. 2013 Dec 1;141(3):1923-33. 

Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic poten­tial of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47(4):293-303.

Dowling RJ, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med. 2011 Apr 6;9:33.

Drugs.com [Internet]. Cabergoline. Copyright © 2013 Wolters Kluwer Health, Inc. Available at: http://www.drugs.com/cdi/cabergoline.html. 10/2/2013. Accessed 10/29/2013.

du Toit PJ, van Aswegen CH, du Plessis DJ. The effect of essential fatty acids on growth and urokinase-type plasminogen activator production in human prostate DU-145 cells. Prostaglandins Leukot Essent Fatty Acids. 1996;55:173-7. 

Duan RD. Anticancer compounds and sphingolipid metabolism in the colon. In Vivo. 2005 Jan-Feb;19(1):293-300. 

Dubuisson JG, Dyess DL, Gaubatz JW. Resveratrol modulates human mammary epithelial cell O-acetyltransferase, sulfo transferase, and kinase activation of the het- erocyclic amine carcinogen N-hydroxy-PhIP. Cancer Lett. 2002 Aug 8;182(1):27-32. 

Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol. 2009 Oct;9(11):1272-80. 

Duffield-Lillico, AJ, Reid, ME, Turnbull, BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 2002;11:630-9. 

Dunlap SM, Chiao LJ, Nogueira L, et al. Dietary energy balance modulates epithe­lial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models. Cancer Prev Res (Phila). 2012 Jul;5(7):930-42.

Egan K, FitzGerald GA. Eicosanoids and the vascular endothelium. Handb Exp Pharmacol. 2006 176 (Pt 1):189-211.

Eichholzer M, Steinbrecher A, Kaaks R, et al. Effects of selenium status, dietary glucosinolate intake and serum glutathione s-transferase a activity on the risk of benign prostatic hyperplasia. BJU Int. 2012 Dec;110(11 Pt C):E879-85. 

El-Bayoumy K. The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis. Nutr Cancer. 2009;61(3):285-6. 

Ellem SJ, Risbridger GP. Aromatase and prostate cancer. Minerva Endocrinol. 2006 Mar;31(1):1-12.

El-Sayed WM, Aboul-Fadl T, Lamb JG, Roberts JC, Franklin MR. Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice. Toxicology. 2006 Mar 15;220(2-3):179-88. 

Erdelyi I, Levenkova N, Lin EY, et al. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J Nutr. 2009 Nov;139(11):2072-8. 

Ersoy C, Kiyici S, Budak F, et al. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Diabetes Res Clin Pract. 2008 Jul;81(1):56-60.

Ervin RB. Prevalence of metabolic syn­drome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003- 2006. Natl Health Stat Report. 2009 May 5;(13):1-7.

Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 1995 Nov;147(2):295-302. 

Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005 Jun 4;330(7503):1304-5

Faloon W. Another Victory Against FDA Censorship. Life Extension Magazine. July 2012.

Faloon W. Protection Against Arterial Calcification, Bone Loss, Cancer, and Aging! Life Extension Magazine. January 2009.

Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005 Mar;19(3):342-53. 

Fang J, Zhou Q, Liu LZ, et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis. 2007 Apr;28(4):858-64. 

Farhan H, Wahala K, Adlercreutz H, et al. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):261-8. 

Faria A, Monteiro R, Azevedo I, Calhau C. Pomegranate juice effects on cytochrome P450S expression: in vivo studies. J Med Food. 2007 Dec;10(4):643-9. 

Faronato M, Muzzonigro G, Milanese G, et al. Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma. Histol Histopathol. 2007 Oct;22(10):1109-18. 

FDA. U.S. Food and Drug Administration. Drugs. 5-Alpha Reductase Inhibitor Information. Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm258424.htm. Last updated 4/11/2013. Accessed 10/24/2013.

FDA. U.S. Food and Drug Administration. Drugs. FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer. Available at: http://www.fda.gov/drugs/drugsafety/ucm258314.htm. Last updated 7/20/2012. Accessed 10/24/2013.

Feldman M, Cryer B, Rushin K, Betancourt J. A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. Clin Appl Thromb Hemost. 2001 Jan;7(1):53-7. 

Ferretti JL. Peripheral Quantitative Computed Tomography (pQCT) For Evaluating Structural and Mechanical Properties of Small Bone. In: Practical Guide for Mechanical Testing of Bone (Ch. 25).” CRC Press, Boca Raton, FL; 1999.

Ferris-Tortajada J, Berbel-Tornero O, Garcia-Castell J, Ortega-Garcia JA, Lopez-Andreu JA. Dietetic factors associated with prostate cancer: protective effects of Medi­terranean diet. Actas urologicas espanolas. 2012 Apr;36(4):239-245.

Flanagan JN, Young MV, Persons KS, et al. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 2006,Jul-Aug;26(4A):2567-72.

Fleischer AC. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications. J Ultrasound Med. 2000 Jan;19(1):55-61.

Fleshner N and Joshua A. University Health Network, Toronto. A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Lower Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2013 [cited 2013 Oct 29]. Available at: http://www.clinicaltrials.gov/ct2/show/NCT01864096. NLM Identifier: NCT01864096.

Fleshner NE, Lucia MS, Egerdie B, et al. Dutasteride in local­ised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. Lancet. 2012 Mar 24;379(9821):1103-11.

Fleshner, N., Fair, W.R., Huryk, R. et al. Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol. 1999;161:1651-4.

Fodor D, Albu A, Poantă L, Porojan M. Vitamin K and vascular calcifications. Acta Physiol Hung. 2010 Sep;97(3):256-66.

Folkers K, Brown R, Judy WV, Morita M. Survival of cancer patients on therapy with coenzyme Q10. Biochem Biophys Res Commun. 1993 Apr 15;192(1):241-5. 

Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun. 1997 May 19;234(2):296-9. 

Folkers K. Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. Biochem Biophys Res Commun. 1996 Jul 16;224(2):358-61. 

Fong AT, Swanson HI, Dashwood RH, Williams DE, Hendricks JD, Bailey GS. Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, eletrophile-scavenging, and inhibition of aflatoxin B1 activation. Biochem Pharmacol. 1990 Jan 1;39(1):19-26. 

Franzen CA, Amargo E, Todorović V, et al. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res (Phila Pa). 2009 Sep;2(9):830-41. 

Freedland SJ, Aronson WJ. Dietary inter­vention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol. 2009 May;19(3):263-7.

Fujiki H, Suganuma M. Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention. Cancer Lett. 2012 Nov 28;324(2):119-25. 

Gallardo-Williams MT, Chapin RE, King PE, et al. Boron supple­mentation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice. Toxicol Pathol. 2004 Jan-Feb;32(1):73-8.

Galli F, Stabile AM, Betti M, et al. The effect of alpha- and gamma- tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch Biochem Biophys. 2004 Mar 1;423(1):97-102. 

Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999;59:1225-30. 

Gao X, LaValley MP, Tucker KL. Prospec­tive studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005 Dec 7;97(23):1768-77.

Garcia Rodriguez LA. The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data. Clin Exp Rheumatol. 2001 Nov;19(6 Suppl 25):S41-4. 

Garikapaty VP, Ashok BT, Chen YG, et al. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncol Rep. 2005 Jan;13(1):89-93.

Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989 Nov 18;2(8673):1176-8. 

Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S-201S. 

Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):708-11. 

Gasmi J, Sanderson JT. Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. J Agric Food Chem. 2010 Nov 10. 

Genomic Health. Genomic Health Announces Availability  of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments. Available at: http://files.shareholder.com/downloads/GHDX/2097290524x0x661617/85f38a0e-ccd5-47de-a348-8d0c2b5c03bd/GHDX_News_2013_5_8_General.pdf. 5/8/2013. Accessed 10/29/2013.

Gerber GS. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep. 2002 Aug;3(4):285-91. 

Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol. 2001 Jan;39(1):11-7. 

Gharaee-Kermani M, Macoska JA. Promis­ing molecular targets and biomarkers for male BPH and LUTS. Curr Urol Rep. 2013 Aug 3.

Ghosh J, Myers CE. Arachidonic acid stim­ulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun. 1997 Jun 18;235(2):418-23.

Ghosh J, Myers CE. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13182-7. 

Ghosh J. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase. Biochem Biophys Res Commun. 2003 Jul 25;307(2):342-9. 

Ghossain A, Ghossain MA. History of mas­tectomy before and after Halsted. J Med Liban. 2009 Apr-Jun;57(2):65-71.

Gion M, Mione R, Barioli P, et al. Percent free prostate-specific antigen in assessing the probability of prostate cancer under opti­mal analytical conditions. Clin Chem. 1998 Dec;44(12):2462-70.

Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995;87:1767-76. 

Giton F, de la Taille A, Allory Y, et al. Es­trone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa). J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):158-67.

Glinsky VV, Raz A. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr Res. 2009 Sep 28;344(14):1788-91. 

Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer. 2010;62(7):919-30. 

Gofrit ON, Zorn KC, Taxy JB, et al. Pre­dicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer. J Urol. 2007 Nov;178(5):1925-8.

Goldmann WH, Sharma AL, Currier SJ, Johnston PD, Rana A, Sharma CP. Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells. Cell Biol Int. 2001;25(11):1117-24. 

Gomez Y, Arocha F, Espinoza F, Fernandez D, Vasquez A, Granadillo V. Zinc levels in prostatic fluid of patients with prostate pathologies. Invest Clin. 2007 Sep;48(3):287-94. 

Gonzalez A, Peters U, Lampe JW, White E. Zinc intake from supplements and diet and prostate cancer. Nutr Cancer. 2009;61(2):206-15. 

Goodman LA, Jarrett CL, Krunkosky TM, et al. 5-Lipoxygenase expression in benign and malignant canine prostate tissues. Vet Comp Oncol. 2011 Jun;9(2):149-57. 

Goodwin JS, Goodwin JM. The tomato effect. Rejection of highly efficacious therapies. JAMA. 1984 May 11;251(18):2387-90.

Gooren L. Androgen deficiency in the aging male: benefits and risks of androgen supplementation. J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):349-55.

Gorham ED, Garland CF, Garland FC, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):179-94. 

Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol. 2008 Aug;110(2):246-50.

Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97.

Gryder BE, Rood MK, Johnson KA, et al. Histone deacetylase inhibitors equipped with estrogen receptor modulation activity. J Med Chem. 2013 Jul 3. 

Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003;6(4):301-4. 

Gukovsky I, Reyes CN, Vaquero EC, Gukovskaya AS, Pandol SJ. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G85-95. 

Guo H, Xu YM, Ye ZQ, Yu JH, Hu XY. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor. Pharmazie. 2013 Jun;68(6):431-4. 

Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a doubleblind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4. 

Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001 Jul;67(5):391-5. 

Gupta K, Thakur VS, Bhaskaran N, et al. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One. 2012;7(12):e52572. 

Gupta RT, Kauffman CR, Polascik TJ, Taneja SS, Rosenkrantz AB. The state of prostate MRI in 2013. Oncology (Williston Park). 2013 Apr;27(4):262-70.

Gupta S, Chiplunkar S, Kim C, Yel L, Gollapudi S. Effect of age on molecular signaling of TNF-alpha-induced apoptosis in human lymphocytes. Mech Ageing Dev. 2003 Apr;124(4):503-9. 

Gupta S, Srivastava M, Ahmad N, et al. Lipoxygenase-5 is overexpressed in pros­tate adenocarcinoma. Cancer. 2001 Feb 15;91(4):737-43.

Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195-218. 

Gysin R, Azzi A, Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002 Dec;16(14):1952-4. 

Haber D. Roads leading to breast cancer. N Engl J Med. 2000 Nov 23;343(21):1566-8. 

Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR. Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells. Int J Oncol. 2013 Jul;43(1):194-200. 

Häggström S, Bergh A, Damber JE. Vas­cular endothelial growth factor content in metastasizing and nonmetastasizing Dun­ning prostatic adenocarcinoma. Prostate. 2000 Sep 15;45(1):42-50.

Hahm ER, Singh SV. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells. Cancer Prev Res (Phila). 2010 Apr;3(4):484-94. 

Hamalainen M, Nieminen R, Asmawi MZ, Vuorela P, Vapaatalo H, Moilanen E. Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages. Planta Med. 2011 Sep;77(13):1504-11. 

Han HY, Shan S, Zhang X, Wang NL, Lu XP, Yao XS. Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L. Phytomedicine. 2007 May;14(5):338-43. 

Handel LN, Agarwal S, Schiff SF, Kelty PJ, Cohen SI. Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy? Urology. 2006 Dec;68(6):1220-3.

Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate. 2007 Oct 1;67(14):1576-89. 

Harris RE. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology. 2009 Apr;17(2):55-67.

Harvei S. Epidemiology of prostatic cancer. Tidsskr Nor Laegeforen 1999 Oct 10;119(24):3589-94. 

Haseltine F, Paulsen C, Wang C, eds. Reproductive Issues and the Aging Male. Washington, D.C: American Association for the Advancement of Science; 1993:15-34.

Hassan S, Carraway RE. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth. Regul Pept. 2006 Jan 15;133(1-3):105-14. 

Hazai E, Bikadi Z, Zsila F, Lockwood SF. Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase. Bioorg Med Chem. 2006 Oct 15;14(20):6859-67. 

Heald CL, Bolton-Smith C, Ritchie MR, Morton MS, Alexander FE. Phyto-oestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older men. Eur J Clin Nutr. 2006 Jan;60(1):129-35. 

Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr. 2007 Aug;98(2):388-96. 

Heath EI, Heilbrun LK, Li J, et al. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3’- Diindolylmethane) in castrateresistant, non-metastatic prostate cancer. Am J Transl Res. 2010 Jul 23;2(4):402-11. 

Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Lett. 2008 Oct 8;269(2):262-8. 

Hedelin M, Klint A, Chang ET, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control. 2006 Mar;17(2):169-80. 

Helzlsouer KJ, Huang, HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92(24):2018-23. 

Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer. 1988 Feb;57(2):216-8.

Henderson K, Stella SL, Kobylewski S, Eckhert CD. Receptor activated Ca(2+) release is inhibited by boric acid in prostate cancer cells. PLoS One. 2009;4(6):e6009. 

Hennig R, Ding XZ, Tong WG, et al. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol. 2002 Aug;161(2):421-8. 

Henning SM, Aronson W, Niu Y, et al. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr. 2006 Jul;136(7):1839-43. 

Herman JG, Stadelman HL, Roselli CE. Curcumin blocks CCL2- induced adhesion, motility and invasion, in part, through downregulation of CCL2 expression and proteolytic activity. Int J Oncol. 2009 May;34(5):1319-27. 

Herschman JD, Smith DS, Catalona WJ. Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Urology. 1997 Aug;50(2):239-43.

Hessels D, Schalken JA. The use of PCA3 in the diagnosis of pros­tate cancer. Nat Rev Urol. 2009 May;6(5):255-61.

Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009 Oct 1;69(19):7507-11.

Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001;12:789-96. 

Hitron A, Adams V, Talbert J, Steinke D. The influence of antidiabetic medications on the development and progression of prostate cancer. Cancer Epidemiol. 2012 Aug;36(4):e243-50.

Ho E, Clarke JD, Dashwood RH. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009 Dec;139(12):2393-6. 

Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006 Jun 1;66(11):5624-32.

Hodges S, Hertz N, Lockwood K, Lister R. CoQ10: could it have a role in cancer management? Biofactors. 1999;9(2-4):365-70. 

Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. 

Hong J, Bose M, Ju J, et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 2004 Sep;25(9):1671-9. 

Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol. 2001 Nov 1;62(9):1175-83. 

Hong JH, Ahn KS, Bae E, Jeon SS, Choi HY. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 2006;9(2):147-52. 

Hong MY, Seeram NP, Heber D. Pomegranate polyphenols downregulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem. 2008 Dec;19(12):848-55. 

Hoque A, Lippman SM, Wu TT, et al. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis. 2005 Apr;26(4):785-91. 

Hostanska K, Suter A, Melzer J, Saller R. Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines. Anticancer Res. 2007 Mar-Apr;27(2):873-81. 

Howcroft TK, Campisi J, Louis GB, et al. The role of inflammation in age-related disease. Aging (Albany NY). 2013 Jan;5(1):84-93.

Hsieh TC, Wu JM. Grape-derived chemo preventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. Anticancer Res. 2000 Jan-Feb;20(1A):225-8. 

Huang EC, McEntee MF, Whelan J. Zyfla­mend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer. Nutr Cancer. 2012 64(5):749-60.

Huang L, Kirschke CP, Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006;6:10. 

Hung CM, Su YH, Lin HY, et al. Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR. J Agric Food Chem. 2012 Aug 16. 

Hussain M, Banerjee M, Sarkar FH, et al. Soy isoflavones in the treatment of pros­tate cancer. Nutr Cancer. 2003 47(2):111-7.

Hvid T, Winding K, Rinnov A, et al. Endur­ance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocr Relat Cancer. 2013 Aug 19;20(5):621-32.

Ibrahiem EI, Mohsen T, Nabeeh AM, Os­man Y, Hekal IA, Abou El-Ghar M. DWI-MRI: single, informative, and noninvasive technique for prostate cancer diagnosis. ScientificWorldJournal. 2012;2012:973450.

IDI. Institute of Diagnostic Imaging. Bone Densitometry. Available at: http://www.idifwb.com/services/exam%20descriptions/bonedensity.htm. Accessed 10/25/2013.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:Cd004720. 

Inohara H, Raz A. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J. 1994 Dec;11(6):527-32. 

Isakovic A, Harhaji L, Stevanovic D, et al. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-depen­dent apoptosis. Cell Mol Life Sci. 2007 May;64(10):1290-302.

Itsiopoulos C, Hodge A, Kaimakamis M. Can the Mediterranean diet prevent prostate cancer? Mol Nutr Food Res. 2009 Feb;53(2):227-39.

Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Controls. 1998 Dec;9(6):553-7. 

Jalving M, Gietema JA, Lefrandt JD, et al. Metformin: taking away the candy for can­cer? Eur J Cancer. 2010 Sep;46(13):2369-80.

James MJ, Penglis PS, Caughey GE, Demasi M, Cleland LG. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response? Inflamm Res. 2001 May;50(5):249-53. 

Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997 Jan 10;275(5297):218-20. 

Jang M, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res. 1999;25(2-3):65-77. 

Jankowska EA, Rozentryt P, Ponikowska B. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009 May 13;301(18):1892-901.

Jeong NH, Song ES, Lee JM, et al. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand. 2009;88(4):457-62.

Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr. 2007;16 Suppl 1:453- 7. 

Jiang Q, Wong J, Ames BN. Gamma-tocopherol induces apoptosis in androgen-responsive LNCaP prostate cancer cells via caspasedependent and independent mechanisms. Ann NY Acad Sci. 2004 Dec;1031:399-400. 

Jiang WG, Douglas-Jones AG, Mansel RE. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):125-34. 

Johansson C, Rytter E, Nygren J, Vessby B, Basu S, Möller L. Down-regulation of oxidative DNA lesions in human mononuclear cells after antioxidant supplementation correlates to increase of gamma-tocopherol. Int J Vitam Nutr Res. 2008 Jul-Sep;78(4-5):183-94.

John EM, Schwartz GG, Koo J, Van Den BD, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005 Jun 15;65(12):5470-9.

John EM, Stern MC, Sinha R, Koo J. Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer. Nutr Cancer. 2011 63(4):525-37. 

Jolliet P, Simon N, Barre J, et al. Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol Ther. 1998 Sep;36(9):506-9. 

Joseph MA, Moysich KB, Freudenheim JL, et al. Cruciferous vegetables, genetic polymorphisms in glutathione Stransferases M1 and T1, and prostate cancer risk. Nutr Cancer. 2004;50(2):206-13. 

Joshi AD, Corral R, Catsburg C, et al. Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study. Carcinogenesis. 2012 Nov;33(11):2108-18. 

Joshua AM, Zannella V, Bowes B, et al. A phase II study of neoadjuvant metformin in prostatic carcinoma [Abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, Illinois. Philadelphia (PA): AACR; 2012. {Abstract CT-04}

Kampa M, Hatzoglou A, Notas G, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer. 2000;37(2):223-33. 

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: pre­liminary study. Urology. 2002 Sep;60(3):464-8.

Karna P, Chagani S, Gundala SR, et al. Benefits of whole ginger extract in prostate cancer. Br J Nutr. 2012 February;107(4):473-84. 

Katiyar SK. Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr Metab Immune Disord Drug Targets. 2006 Mar;6(1):17-24. 

Kaur M, Agarwal C, Agarwal R. Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutr. 2009 Sep;139(9):1806S-12S 

Kenfield SA, Chang ST, Chan JM. Diet and lifestyle interventions in active surveil­lance patients with favorable-risk prostate cancer. Curr Treat Options Oncol. 2007 Jun;8(3):173-96.

Kenfield SA, Dupre N, Richman EL, et al. Mediterranean diet and prostate cancer risk and mortality in the Health Profes­sionals Follow-up Study. Eur Urol. 2013 Aug 13.

Khan N, Adhami VM, Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer. 2010 Mar;17(1):R39-52. 

Killian PH, Kronski E, Michalik KM, et al. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012 Dec;33(12):2507-19. 

Kim KM, Song JJ, An JY, Kwon YT, Lee YJ. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. J Biol Chem. 2005 Dec 9;280(49):41047-56.

Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomedicine. 2003 Jan;10(1):3-7. 

Kimura T. East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer. 2012 Sep;31(9):421-9. 

Kindblom J. 2003. Role of Prolactin in the Prostate Gland – Studies in Transgenic Mouse Models. (Doctoral thesis). Available at: http://www.neurophys.gu.se/digitalAssets/1278/1278430_AVHANDLINGSRAM__Jon_Kindblom.pdf. Accessed 10/24/2013.

Kirsh VA, Peters U, Mayne ST, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007 Aug 1;99(15):1200-9. 

Klein EA, Thompson IM, Jr., Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12;306(14):1549-56. 

Knezevich EL, Knezevick JT, Spangler ML. Benign Prostatic Hyperplasia and the Medication Management of Associated Lower Urinary Tract Symptoms. 5-alpha-reductase Inhibitors. Available at: http://www.medscape.com/viewarticle/745454_4. Accessed 10/29/2013.

Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y. Implica­tions of insulin-like growth factor-I for prostate cancer therapies. Int J Urol. 2009 Feb;16(2):161-7.

Kong HY, Byun J. Emerging roles of Human prostatic acid phos­phatase. Biomol Ther (Seoul). 2013 Jan;21(1):10-20.

Krejcarek SC, Chen MH, Renshaw AA, Loffredo M, Sussman B, D’Amico AV. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer. Urology. 2007 Mar;69(3):515-9.

Krishnan AV, Peehl DM, Feldman D. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. J Cell Biochem. 2003 Feb 1;88(2):363-71.

Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer. 2002;42(1):1-9. 

Kristal AR, Till C, Tangen CM, et al. As­sociations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1823-32.

Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001;10:861-8. 

Kulkarni GS, Al-Azab R, Lockwood G, et al. Evidence for a biopsy derived grade artifact among larger prostate glands. J Urol. 2006 Feb;175(2):505-9

Kumar NB, Cantor A, Allen K, et al. The specific role of isoflavones in reducing prostate cancer risk. Prostate. 2004 May 1;59(2):141-7. 

Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008 Oct 8;269(2):199-225. 

Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008 Jan 1;167(1):71-7. 

LabCorp. Test Menu. Prostate-specific Antigen (PSA), Serum. LabCorp web page. Available at: https://www.labcorp.com/wps/portal/!ut/p/c1/hY1LDoIwFADP4gFMX1uosFUBRUrED4bQsAghj9Gg6eXC6iZ5WQyKEUrXf6sq_xR913eoBilLBMK44JwAopLdCCU7UEaBgMtvrkuwf4U_NT315RgtJdFmqSj02Vgmf4BEyfehInnDEFUIBikDL_DoPrzJ37Vr2zo8nc0SavsCcIRpjfi2qDKG3rUjbNKKIqCo_VjeJiobYudCthLV4_yc_P0MYvvBWbDxFxgk!/dl2/d1/L0lJS2FZQSEhL3dMRUJGcUFFQWpNQy9ZSTV5bHchIS83X1VFNFMxSTkzME9HUzIwSVMzTzROMk42NjgwL3ZpZXdUZXN0/?testId=408050.  Copyright © 2013 Laboratory Corporation of America. Accessed 10/24/2013a.

LabCorp. Test Menu. Vitamin D, 25-Hydroxy. LabCorp web page. Available at: https://www.labcorp.com/wps/portal/!ut/p/c1/hY1LDoIwFADP4gFMHwUrbFVAhRZqNXw2hKBBlD9EQ08vF1Azy8lkUIxm6vRV5OlYNHVaohDFJOE6YRwzDDrFFmCVbGC1NRWwyeyj7x7gT832TXVDEYrXycXUhHIwVPBsgeEgVE9jmBGiAzqjELREPKCl7lBTaXia66Ya_Ze5vRw7mCQkEAvzrH07UsOx7kQejS5yAy6UvLkpBNqmPx_W68czr_op_tgrfypIvPv02K8Q!/dl2/d1/L0lJS2FZQSEhL3dMRUJGcUFFQWpNQy9ZSTV5bHchIS83X1VFNFMxSTkzME9HUzIwSVMzTzROMk42NjgwL3ZpZXdUZXN0/?testId=408405. Copyright © 2013 Laboratory Corporation of America. Accessed 10/24/2013b.

Lakshman M, Xu L, Ananthanarayanan V, et al. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res. 2008 Mar 15;68(6):2024-32.

Lalithakumari K, Krishnaraju AV, Sengupta K, Subbaraju GV, Chatterjee A. Safety and toxicological evaluation of a novel, standardized 3-O-acetyl-11-keto-beta-boswellic acid (AKBA)-enriched Boswellia serrata extract (5-Loxin®(R)). Toxicol Mech Methods. 2006;16(4):199-226. 

Lamblin F, Hano C, Fliniaux O, Mesnard F, Fliniaux MA, Laine E. Interest of lignans in prevention and treatment of cancers. Med Sci (Paris). 2008 May;24(5):511-9. 

Lamson DW and Plaza SM. The Anticancer Effects of Vitamin K. Alt Med Rev. 2003;8(3): 303-318.

Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MK, Venning G. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer. 2011 Oct 11;105(8):1107-13.

Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109(2):177-206. 

Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN. The effect of turmeric extracts on inflammatory mediator pro­duction. Phytomedicine. 2005 Jun;12(6- 7):445-52.

Larre S, Tran N, Fan C, et al. PGE2 and LTB4 tissue levels in benign and cancerous prostates. Prostaglandins Other Lipid Mediat. 2008 Dec;87(1-4):14-9. 

Lasalvia-Prisco E, Cucchi S, Vazquez J, Lasalvia-Galante E, Golomar W, Gordon W. Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer. Med Oncol. 2003;20(1):45-52. 

Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol. 2003 Sep;15(5):623-7. 

Lee EH, Myung SK, Jeon YJ, et al. Effects of selenium supplements on cancer prevention: Meta-analysis of randomized controlled trials. Nutr Cancer. 2011 Nov;63(8):1185-95. 

Lee J, Im YH, Jung HH, et al. Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun. 2005 Aug 26;334(2):313-8. 

Lee MM, Gomez SL, Chang JS, et al. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):665-8. 

Lee ST, Wu YL, Chien LH, Chen ST, Tzeng YK, Wu TF. Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell. Proteomics. 2012 Nov;12(21):3251-62. 

Lee YH, Kwak J, Choi HK, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int J Mol Med. 2012 Jul;30(1):69-74. 

Lee YJ, Lee DM, Lee CH, et al. Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves over-expression of Cyr61. Toxicol In Vitro. 2011 Feb;25(1):199-205. 

LeFevre M. A Role for Finasteride in the Prevention of Prostate Cancer? NEJM. 2013; 369:670-671.

Leitzmann MF, Stampfer MJ, Michaud DS, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr. 2004 Jul;80(1):204-16. 

Lhoste EF, Gloux K, De W, I, et al. The activities of several detoxication enzymes are differentially induced by juices of garden cress, water cress and mustard in human HepG2 cells. Chem Biol Interact. 2004 Dec 7;150(3):211-9. 

Li Y, Chinni SR, Sarkar FH. Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. Front Biosci. 2005 Jan 1;10:236- 43. 

Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999 Aug 1;40(3):200-7.

Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009 Sep;32(9):1620-5.

Lieberman S. Can percent free prostate-specific antigen reduce the need for prostate biopsy? Eff Clin Pract. 1999 Nov- Dec;2(6):266-71.

Ligthart ST, Coumans FA, Bidard FC, et al. Circulating tumor cells count and morphological features in breast, colorectal and prostate cancer. PLoS One. 2013 Jun 27;8(6):e67148.

Ling MT, Lau TC, Zhou C, et al. Over­expression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis. 2005 Oct;26(10):1668-76.

Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 7;301(1):39-51. 

Liu J-J, Nilsson A, Oredsson S, Badmaev V, Zhao W, Duan R. Boswellic acids trigger apoptosis via a pathway dependent on caspase- 8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis. Dec 2002;23(12):2087-93. 

Liu KC, Yen CY, Wu RS, et al. The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin-mediated cell death of human prostate cancer PC-3 cells. Environ Toxicol. 2012. doi: 10.1002/tox.21769. Epub March 20, 2012. 

Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in ‘high risk’ patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med. 1994;15 Suppls231-s40. 

Loeb S, Berglund A, Stattin P. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer. J Urol. 2013 May 30. 

Loeb S, Carter HB. Point: Impact of prostate-specific antigen velocity on management decisions and recommenda­tions. J Natl Compr Canc Netw. 2013 Mar 1;11(3):281-5.

Lou YR, Qiao S, Talonpoika R, Syvala H, Tuohimaa P. The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004 Nov;92(4):317-25.

Loubière C, Dirat B, Tanti JF, Bost F. New perspectives for metformin in cancer therapy. Ann Endocrinol (Paris). 2013 May;74(2):130-6.

Lowe JF, Frazee LA. Update on prostate cancer chemoprevention. Pharmacotherapy. 2006 Mar;26(3):353-9. 

Lu QY, Hung JC, Heber D, et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):749-56. 

Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits anti-estrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999 Jun;179(3):297-304. 

Lucia MS, Epstein JI, Goodman PJ, et al. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Sep 19;99(18):1375-83.

Lunoe K, Gabel-Jensen C, Sturup S, Andresen L, Skov S, Gammelgaard B. Investigation of the selenium metabolism in cancer cell lines. Metallomics. 2011 Feb;3(2):162-8. 

Luo H, Jiang BH, King SM, Chen YC. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer. 2008;60(6):800-9. 

Luo J, Dunn TA, Ewing CM, Walsh PC, Isaacs WB. Decreased gene expression of steroid 5 alpha-reductase 2 in human pros­tate cancer: implications for finasteride therapy of prostate carcinoma. Prostate. 2003 Oct 1;57(2):134-9.

Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010 Mar;6(3):457-70.

Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA. 2005 Oct 11;102(41):14813-8. 

Malik A, Mukhtar H. Prostate cancer prevention through pomegranate fruit. Cell Cycle. 2006 Feb;5(4):371-3. 

Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihy­droxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000 Aug 4;87(3):214-20.

Marshall DT, Savage SJ, Garrett-Mayer E, et al. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul;97(7):2315-24.

Marshall JR, Ip C, Romano K, et al. Methyl Selenocysteine: singledose pharmacokinetics in men. Cancer Prev Res (Phila). 2011 Nov;4(11):1938-44. 

Masko EM, Allott EH, Freedland SJ. The relationship between nutrition and prostate cancer: is more always better? Eur Urol. 2013 May;63(5):810-20.

Matsuyama M, Yoshimura R, Mitsuhashi M, et al. Expression of lipoxygenase in human prostate cancer and growth reduc­tion by its inhibitors. Int J Oncol. 2004 Apr;24(4):821-7.

McCann MJ, Gill CI, Linton T, Berrar D, McGlynn H, Rowland IR. Enterolactone restricts the proliferation of the LNCaP hu­man prostate cancer cell line in vitro. Mol Nutr Food Res. 2008 May;52(5):567-80.

McCann SE, Ambrosone CB, Moysich KB, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer. 2005 53(1):33-41. 

McCarthy S, Caporali A, Enkemann S, et al. Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer. Mol Oncol. 2007 Sep;1(2):196-204. 

McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vas­cular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila). 2009 Jul;2(7):673-82.

Meacham S, Karakas S, Wallace, A, et al. Boron in Human Health: Evidence for Dietary Recommendations and Public Policies. The Open Mineral Processing Journal. 2010;3:36-53.

Meirelles ES, Borelli A, Camargo OP. Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin. Rheumatol. 1999;18:364–8.

Mekki N, Charbonnier M, Borel P, et al. Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr. 2002 Dec;132(12):3642-9. 

Melchini A, Traka MH, Catania S, et al. Antiproliferative activity of the dietary isothiocyanate erucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells. Nutr Cancer. 2013;65(1):132-8. 

Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metfor­min prevents tobacco carcinogen—in­duced lung tumorigenesis. Cancer Prev Res (Phila). 2010 Sep;3(9):1066-76.

Meyer F, Galan P, Douville P, et al. Antioxi­dant vitamin and mineral supplementa­tion and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer. 2005 Aug 20;116(2):182-6.

Miano L. Mediterranean diet, micronutri­ents and prostate carcinoma: a ratio­nale approach to primary prevention of prostate cancer. Arch Ital Urol Androl. 2003 Sep;75(3):166-78.

Michaud DS, Augustsson K, Rimm EB, Stampfer MJ, Willet WC, Giovannucci E. A prospective study on intake of animal products and risk of prostate cancer. Can­cer Causes Control. 2001 Aug;12(6):557-67.

Miller MC, Doyle GV, Terstappen LW. Significance of circulat­ing tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol. 2010;2010:617421.

Mitchell SH, Zhu W, Young CY. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 1999 Dec 1;59(23):5892-5. 

Miwa Y, Kaneda T, Yokoyama O. Correlation between the Ag­ing Males’ Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med. 2006 Jul;3(4):723-6.

Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. J Urol. 2000 Sep;164(3 Pt 1):800-5. 

Monga N, Sayani A, Rubinger DA, Wilson TH, Su Z. The effect of dutasteride on the detection of prostate cancer: A set of meta-analyses. Can Urol Assoc J. 2013 Mar-Apr;7(3-4):E161-7.

Moore G. A Call to Action: The story of the Prostate Cancer Foundation. Santa Monica, CA. Copyright © 2005: 13-18.

Moreira Leite KR, Camara-Lopes LH, Dall’Oglio MF, et al. Up­grading the Gleason score in extended prostate biopsy: implica­tions for treatment choice. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):353-6.

Moretti RM, Montagnani MM, Sala A, Motta M, Limonta P. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase. Int J Cancer. 2004 Oct 20;112(1):87-93. 

Morgentaler A. Testosterone replacement therapy and prostate cancer. Urol Clin North Am. 2007 Nov;34(4):555-63.

Moyad MA, Brumfield SK, Pienta KJ. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol. 1999 May;17(2):85-90. 

Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommen­dation statement. Ann Intern Med. 2012 Jul 17;157(2):120-34.

MSKCC. Memorial Sloan-Kettering Cancer Center. Integrative Medicine. About Herbs, Botanicals & Other Products. Resveratrol. Available at: http://www.mskcc.org/cancer-care/herb/resveratrol. Last updated 3/19/2013a. Accessed 10/21/2013.

MSKCC. Memorial Sloan-Kettering Cancer Center. Integrative Medicine. About Herbs, Botanicals & Other Prodeucts. N-Acetylcysteine. Available at: http://www.mskcc.org/cancer-care/herb/n-acetylcysteine. Last updated 4/9/2013b. Accessed 10/21/2013.

Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, Voutilainen S. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer. 2008;123:660-3. 

Muti P, Westerlind K, Wu T, et al. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States. Cancer Causes Control. 2002 Dec;13(10):947-55. 

Myriad. Prolaris®: A Prognostic Medicine Product for Prostate Cancer. Myriad Products web page. Available at: http://www.myriad.com/products/prolaris/. Accessed 10/29/2013.

Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. Faseb j. 2006 Mar;20(3):506-8. 

Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007 Feb;232(2):227-34. 

Nagi DK, Yudkin JS. Effects of metfor­min on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care. 1993 16(4):621-29.

Nair HK, Rao KV, Aalinkeel R, Mahajan S, Chawda R, Schwartz SA. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. 

Nakamura K, Yasunaga Y, Segawa T, et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol. 2002;21(4):825-30. 

Nangia-Makker P, Hogan V, Honjo Y, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62. 

Narayanan BA, Narayanan NK, Re GG, Nixon DW. Differential expression of genes induced by resveratrol in LNCaP cells: P53- mediated molecular targets. Int J Cancer. 2003 Mar 20;104(2):204- 12. 

Nassiri-Asl M, Hosseinzadeh H. Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds. Phytother Res. 2009;23:1197-1204. 

Nayyar R, Singh P, Gupta NP, et al. Upgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience. Indian J Urol. 2010 Jan- Mar;26(1):56-9.

NCI. National Cancer Institute. Coenzyme Q10 (PDQ®): Questions and Answers About Coenzyme Q10. Accessed 10/21/2013a.

NCI. National Cancer Institute. National Cancer Institute FactSheet. Chemicals in Meat Cooked at High Temperatures and Cancer Risk. Available at:  http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats. Last reviewed 10/15/2010. Accessed 10/18/2013.

NCI. National Cancer Institute. NCI Dictionary of Cancer Terms. Aggressive. Available at: http://www.cancer.gov/dictionary?cdrid=46053. Accessed 10/18/2013b.

NCI. National Cancer Institute. Prostate Cancer Prevention Trial (PCPT). News page. Available at: http://www.cancer.gov/newscenter/qa/2008/PCPTQandA. Last updated 8/14/2013c. Accessed 10/14/2013.

NCI. National Cancer Institute. Prostate-Specific Antigen (PSA) Test. Available at: http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Last updated 7/24/2012. Accessed 10/24/2013.

NCI. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer Statistics page. Fast Stats. http://seer.cancer.gov/faststats/selections.php?run=runit&output=2&data=2&statistic=1&year=201302&race=1&sex=2&age=1&series=cancer&cancer=66#Output. 4/2013d. Accessed 10/29/2013.

Nelles JL, Hu WY, Prins GS. Estrogen action and prostate cancer. Expert Rev Endocrinol Metab. 2011 May;6(3):437-451.

Nelson R. Dutasteride Enhances Predictive Usefulness of PSA Test. Available at: http://www.medscape.com/viewarticle/734687. 12/21/2010. Accessed 10/29/2013.

Nelson R. Finasteride Does Not Increase Risk for High-Grade Prostate Cancer. Clin Cancer Res. 2009; 15:4694-4699.

Nelson WG, DeMarzo AM, DeWeese TL, et al. The role of inflammation in the pathogenesis of prostate cancer. J Urol. 2004 Nov;172(5 Pt 2):S6-11.

Newcomer LM, King IB, Wicklund KG, Stanford JL. The association of fatty acids with prostate cancer risk. Prostate. 2001 Jun 1;47(4):262-8. 

Nickel JC. Comparison of clinical trials with finasteride and dutasteride. Rev Urol. 2004;6 Suppl 9:S31-9.

Nie D, Lamberti M, Zacharek A, et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun. 2000 Jan 7;267(1):245-51. 

NIH. National Institutes of Health: Office of Dietary Supplements. Dietary Supplement Fact Sheet: Selenium. Health Information page. Available at: http://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/. 7/2/2013. Accessed 10/21/2013.

Nimptsch K, Rohrmann S, Linseisen J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2008 Apr;87(4):985-92. 

Nishiyama T. (2011). Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer. In: Prostate Cancer - From Bench to Bedside, Dr. Philippe E. Spiess (Ed.), ISBN: 978-953-307-331-6, InTech, Available at: http://cdn.intechopen.com/pdfs/24233/Inech-Paradigm_shift_in_the_concept_of_hormonal_milieu_of_prostate_cancer.pdf.

Niture SK, Refai L. Plant pectin: A potential source of cancer suppression. Amer J Pharmacol Toxicol, 2013;8(1):9-19. 

Norris PC, Dennis EA. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci U S A. 2012 May 29;109(22):8517-22. 

Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ, Jackson RT. Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer. 1999 Dec;81(7):1238-42.

Numao N, Kawakami S, Sakura M, et al. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int. 2012 Mar;109(5):665-71.

O’Dowd GJ, Veltri RW, Miller MC, et al. The Gleason Score: A Significant Biologic Manifestation of Prostate Cancer Aggressiveness On Biopsy. Prostate Cancer Research Institute (PCRI) web page. Available at: http://prostate-cancer.org/the-gleason-score-a-significant-biologic-manifestation-of-prostate-cancer-aggressiveness-on-biopsy/. Reprinted from PCRI Insights January 2001; v4.1. Accessed 10/24/2013.

O’Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O’Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res. 2004 Jul 13;551(1-2):245-54. 

O’Sullivan J, Sheridan J, Mulcahy H, Tenniswood M, Morrissey C. The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats. Eur J Cancer Prev. 2008 Nov;17(6):489-501. 

Obermuller-Jevic UC, Olano-Martin E, Corbacho AM, et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr. 2003;133:3356-60. 

Ong KW, Hsu A, Tan BK. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol. 2013 May 1;85(9):1341-51.

Onguru O, Casey MB, Kajita S, Nakamura N, Lloyd RV. Cyclooxygenase- 2 and thromboxane synthase in non-endocrine and endocrine tumors: a review. Endocr Pathol. 2005 16(4):253-77. 

Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8369-74.

Ozasa K, Nakao M, Watanabe Y, et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci. 2004 Jan;95(1):65-71. 

Pais P. Potency of a novel saw palmetto ethanol extract, SPET- 085, for inhibition of 5alpha-reductase II. Adv Ther. 2010 Aug;27(8):555-63. 

Palaniswamy UR, McAvoy RJ, Bible BB, Stuart JD. Ontogenic variations of ascorbic acid and phenethyl isothiocyanate concentrations in watercress (Nasturtium officinale R.Br.) leaves. J Agric Food Chem. 2003 Aug 27;51(18):5504-9. 

Paller CJ, Ye X, Wozniak PJ, et al. A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2013 Mar;16(1):50-5. 

Pandey M, Gupta S. Green tea and prostate cancer: from bench to clinic. Front Biosci (Elite Ed). 2009;1:13-25. 

Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 1;12(13):4018-26. 

Parekh N, Lin Y, Vadiveloo M, Hayes RB, Lu-Yao GL. Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham Heart Study-Offspring Cohort (1971-2008). Cancer Epidemiol Biomarkers Prev. 2013 Sep 24.

Park C, Kim GY, Kim GD, et al. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep. 2006 May;15(5):1225-31. 

Park HJ, Jeon YK, You DH, Nam MJ. Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol. 2013 Oct;60:542-9. 

Patterson K. A Patient’s Guide to Bone Health. Published in CURE. Available at: http://media.curetoday.com/downloads/documents/BoneHealth_PG_rev_b.pdf. Fall 2010.

PCCNC. Prostate Cancer Coalition of North Carolina. Prostate Cancer Awareness. Available at: http://www.pccnc.org/awareness/. Accessed 10/28/2013.

PCF. Prostate Cancer Foundation. Prostate Cancer FAQs. Available at: http://www.pcf.org/site/c.leJRIROrEpH/b.5800851/k.645A/Prostate_Cancer_FAQs.htm. 2013a. Accessed 10/24/2013.

PCF. Prostate Cancer Foundation. Understanding Prostate Cancer: Prostate Cancer Risk Factors. Available at: http://www.pcf.org/site/c.leJRIROrEpH/b.5802027/k.D271/Prostate_Cancer_Risk_Factors.htm. Copyright © 2013b. Accessed 10/25/2013.

PCRI. Prostate Cancer Research Institute. Diagnostic Imaging. Available at: http://prostate-cancer.org/decision-aide/understanding-your-diagnosis/diagnostic-imaging/. Last updated 8/1/2011. Accessed 10/24/2013.

Pelser C, Mondul AM, Hollenbeck AR, Park Y. Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707 

Perumal SS, Shanthi P, Sachdanandam P. Energy-modulating vitamins—a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. Br J Nutr. 2005 Jun;93(6):901-9. 

Pezzato E, Sartor L, Dell’Aica I, et al. Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-) epigallocatechin-3-gallate. Int J Cancer. 2004 Dec 10;112(5):787-92.

Pham H, Ziboh VA. 5a-Reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids. Steroid Biochem Mol Biol. 2002;82:393-400. 

Pienta KJ, Naik H, Akhtar A, et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995;87:348-53. 

Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast cancer: a casecontrol study in eastern Finland. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44. 

Piller R, Chang-Claude J, Linseisen J. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev. 2006 Jun;15(3):225-32. 

Pitchakarn P, Chewonarin T, Ogawa K, et al. Ellagic Acid inhibits migration and invasion by prostate cancer cell lines. Asian Pac J Cancer Prev. 2013;14(5):2859-63. 

Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene. 1999 Oct 28;18(44):6013-20. 

Polesel J, Talamini R, Montella M, et al. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol. 2006 Apr;17(4):713-8. 

Pollack CE, Platz EA, Bhavsar NA, et al. Primary care providers’ perspectives on discontinuing prostate cancer screening. Cancer. 2012 Nov 15;118(22):5518-24.

Portakal O, Ozkaya O, Erden IM, et al. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem. 2000 Jun;33(4): 279-84. 

Post PN, Kil PJ, Hendrikx AJ, Janssen- Heijnen ML, Crommelin MA, Coebergh JW. Comorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int. 1999 Oct;84(6):652-6.

Prins GS, Birch L, Couse JF, et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001 Aug 15;61(16):6089-97.

Prins GS, Birch L, Tang WY, Ho SM. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol. 2007 Apr;23(3):374-82.

Prins GS, Tang WY, Belmonte J, Ho SM. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):134-8. 

Pruthi RS, Derksen JE, Moore D, et al. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2172-7.

Punnen S, Hardin J, Cheng I, Klein EA, Witte JS. Impact of meat consumption, preparation, and mutagens on aggres­sive prostate cancer. PLoS One. 2011 6(11):e27711.

Qaseem A, Barry MJ, Denberg TD, et al. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013 May 21;158(10):761-9.

Qin W, Smith C, Jensen M, Holick MF, Sauter ER. Vitamin d favorably alters the cancer promoting prostaglandin cascade. Anticancer Res. 2013 Sep;33(9):3861-6.

Qu T, Uz T, Manev H. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol Aging. 2000 Sep- Oct;21(5):647-52. 

Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998 Apr;159(4):1247-50.

Rafi MM, Kanakasabai S, Reyes MD, Bright JJ. Lycopene modulates growth and survival associated genes in prostate cancer. J Nutr Biochem. 2013 Oct;24(10):1724-34. 

Raina K, Ravichandran K, Rajamanickam S, Huber KM, Serkova NJ, Agarwal R. Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: a multiparametric magnetic resonance study. Cancer Prev Res. January 2013;6:40-50. 

Raina K, Singh RP, Agarwal R, Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res. 2007;67:5976-82. 

Rajashekhar G, Willuweit A, Patterson CE, et al. Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res. 2006 43(2):193-204. 

Rao KV, Samikkannu T, Dakshayani KB, et al. Chemopreventive potential of an ethyl acetate fraction from Curcuma longa is associated with upregulation of p57(kip2) and Rad9 in the PC-3M prostate cancer cell line. Asian Pac J Cancer Prev. 2012;13(3): 1031-8. 

Ravindran J, Prasad S, Aggarwal BB. Cur­cumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009 Sep;11(3):495-510.

Raynaud JP. Prostate cancer risk in testos­terone-treated men. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):261-6.

Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659-61. 

Redman MW, Tangen CM, Goodman PJ, et al. Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach. Cancer Prev Res. 2008; 1:174-181.

Ren S, Lien EJ. Natural products and their derivatives as cancer chemopreventive agents. Prog Drug Res. 1997;48:147-71. 

Reuter S, Gupta SC, Park B, Goel A, Ag­garwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011 May;6(2):93-108.

Rhoden EL, Averbeck MA, Teloken PE. Androgen replacement in men under-going treatment for prostate cancer. J Sex Med. 2008 Sep;5(9):2202-8.

Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011 Dec;4(12):2110-21. 

Riehl TE, Turk J, and Stetson WF. Metabolism of oxygenated derivatives of arachidonic acid by Caco-2 cells. Journal of Lipid Research. 1992:33: 323-331.

Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R. Effect of antioxi­dants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells. J Natl Cancer Inst. 1999 Jul 21;91(14):1227-32.

Ritch CR, Wan RL, Stephens LB, et al. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol. 2007 Jan;177(1):97-101; discussion 101. 

Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008 Feb 6;100(3):170-83.

Rodriguez-Berriguete G, Sanchez-Espiridion B, Cansino JR, et al. Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer. Cytokine. 2013 Sep 21. 

Roehrborn C. Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice. European Urology Supplements 5 (2006) 698-703.

Rogan EG. The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo. 2006 Mar-Apr;20 (2):221-8. 

Rosillo MA, Sanchez-Hidalgo M, Cardeno A, et al. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res. 2012 Sep;66(3):235-42. 

Roy S, Khanna S, Shah H, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 2005 Apr;24(4):244-55. 

Rubinsztajn R, Wronska J, Chazan R. Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge. Pol Arch Med Wewn. 2003 Aug;110(2):849-54. 

Rusciani L, Proietti I, Rusciani A, et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol. 2006 Feb;54(2):234-41. 

Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. 1997 Apr;281(1):460-3. 

Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol. 1995 Jun;47(6):1212-6.

Sailer ER, Subramanian LR, Rall B, et al. Acetyl-11-keto-betaboswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol. 1996 Feb;117(4):615-8. 

Sakr WA, Grignon DJ, Haas GP, et al. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract. 1995 Sep;191(9):838-41.

Salinas CA, Kwon EM, FitzGerald LM, et al. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol. 2010 Sep 1;172(5):578-90.

Sampson AP. FLAP inhibitors for the treatment of inflammatory diseases. Curr Opin Investig Drugs. 2009 Nov;10(11):1163-72. 

Sandur SK, Ahn KS, Ichikawa H, et al. Zy­flamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products. Nutr Cancer. 2007 57(1):78-87.

Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. 

Sartippour MR, Seeram NP, Rao JY, et al. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008 Feb;32(2):475-80. 

Saruwatari A, Okamura S, Nakajima Y, Narukawa Y, Takeda T, Tamura H. Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J Med Food. 2008 Dec;11(4):623-8. 

Schleicher RL, Lamartiniere CA, Zheng M, et al. The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma. Cancer Lett. 1999 Mar 1;136(2):195-201. 

Schmidt LJ, Regan KM, Anderson SK, Sun Z, Ballman KV, Tindall DJ. Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xeno­grafts. Prostate. 2009 Dec 1;69(16):1730-43.

Schmidt LJ, Tindall DJ. Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer. J Steroid Biochem Mol Biol. 2011 May;125(1-2):32-8.

Schwartz J. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr. 2000 Jan;71(1 Suppl):393S-6S. 

Sears B, Ricordi C. Anti-inflammatory nutrition as a pharmacological approach to treat obesity. J Obes. 2011;2011. 

Seeni A, Takahashi S, Takeshita K, et al. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev. 2008 Jan-Mar;9(1):7-14. 

Seeram NP, Aronson WJ, Zhang Y, et al. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem. 2007 Sep 19;55(19):7732-7. 

SELF. SELF Nutrition Data web page. 2012. Foods highest in Total Omega-6 fatty acids. Available at: http://nutritiondata.self.com/foods-000141000000000000000-w.html. Accessed 10/18/2013.

Selvi BR, Batta K, Kishore AH, et al. Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. J Biol Chem. 2010 Mar 5;285(10):7143-52. 

Senthilkumar K, Arunkumar R, Elumalai P, et al. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011 Mar;29(2):87-95. 

Sethi BK, Chanukya GV, Nagesh VS. Prolactin and cancer: Has the orphan finally found a home? Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S195-8.

Shah S, Prasad S, Knudsen KE. Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. Cancer Res. 2012 Mar 1;72(5):1248-59. 

Shamsuddin AM, Yang GY. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis. 1995 Aug;16(8):1975-9. 

Shankar S, Ganapathy S, Chen Q, Srivastava RK. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer. 2008;7:16. 

Shapiro RH, Johnstone PA. Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance. Urology. 2012 Sep;80(3):661-6.

Shelton PQ, Ivanowicz AN, Wakeman CM, et al. Active surveil­lance of very-low-risk prostate cancer in the setting of active treat­ment of benign prostatic hyperplasia with 5α-reductase inhibitors. Urology. 2013 May;81(5):979-84.

Shen JC, Klein RD, Wei Q, et al. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Mol Carcinog. 2000 Oct;29(2):92-102. 

Shepherd BE, Redman MW, Ankerst DP. Does finasteride affect the severity of prostate cancer? A causal sensitivity analysis. J Am Stat Assoc. 2008 Dec 1;103(484):1392-404.

Shi Q, Shih CC, Lee KH. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity. Anticancer Agents Med Chem. 2009 Oct;9(8):904-12. 

Shimamoto T, Ashida S, Yamasaki I, et al. The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Hinyokika Kiyo. 2012 Mar;58(3):143-8.

Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Curr Probl Cancer. 2007 Jul-Aug;31(4):243-305. 

Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by cur­cumin. Adv Exp Med Biol. 2007 595:127-48.

Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 2;104(9):690-9. 

Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1betainduced PGE2 production in human chondrocytes in vitro. J Inflamm (Lond). 2008 Jun 13;5:9. 

Shukla S, Gupta S. Apigenin: A promising molecule for cancer prevention. Pharm Res. 2010 June;27(6):962-78. 

Shukla S, Mishra A, Fu P, Maclennan GT, Resnick MI, Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J. 2005 Dec;19(14):2042-44. 

Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007 May;45(5):683-90. 

Siddiqui IA, Asim M, Hafeez BB, Adhami VM, Tarapore RS, Mukhtar H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. Faseb j. 2011 Apr;25(4):1198-207. 

Siddiqui IA, Zaman N, Aziz MH, et al. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis. 2006 Apr;27(4):833-9. 

Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011 May;73(3):255-61. 

Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012;62:10-29.

Sineh Sepehr K, Baradaran B, Mazandarani M, Khori V, Shahneh FZ. Studies on the cytotoxic activities of Punica granatum L. var. spinosa (Apple Punice) extract on prostate cell line by induction of apoptosis. ISRN Pharm. 2012;2012:547942. 

Singh PB, Matanhelia SS, Martin FL. A potential paradox in prostate adeno­carcinoma progression: oestrogen as the initiating driver. Eur J Cancer. 2008 May;44(7):928-36.

Singh RP, Agarwal R. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res. 2004b Nov 2;555(1-2):21-32. 

Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Curr Cancer Drug Targets. 2004a Feb;4(1):1-11. 

Singh RP, Raina K, Sharma G, Agarwal, R. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angio­genesis and epithelial-mesenchymal transi­tion in transgenic adenocarcinoma of the mouse prostate model mice. Clin Cancer Res. 2008 Dec 1;14(23):7773-80.

Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apopotosis, and inhibition of angiogenesis. Cancer Epidemiol Biomarkers Prev. 2003 Sept;12(9):933-9. 

Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C, Agarwal R. In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulinlike growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res. 2004c Jan 1;10(1 Pt 1):244-50. 

Sirab N, Robert G, Fasolo V, et al. Lipidosterolic extract of serenoa repens modulates the expression of inflammation relatedgenes in benign prostatic hyperplasia epithelial and stromal cells. Int J Mol Sci. 2013 Jul 10;14(7):14301-20. 

SJPHS. St. John Providence Health System. Tumor Factors Defining the Extent and Severity of Cancer. Providence Prostate Cancer Evaluation page. Available at: http://www.stjohnprovidence.org/InnerPage.aspx?PageID=1446. Copyright © 2013. Accessed 10/29/2013.

Skinner HG, Michaud DS, Giovannucci E, et al. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95. 

Smith S, Sepkovic D, Bradlow HL, Auborn KJ. 3,3’-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells. J Nutr. 2008 Dec;138(12):2379-85.

Smith, M.R., McGovern, F.J., Fallon, M.A. et al. Low bone mineral density in hormone-naive men with prostate carcinoma. Cancer. 2001;91:2238–45.

Soares ND, Teodoro AJ, Oliveira FL, et al. Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells. Nutr Cancer. 2013 Sep 20. 

Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008 Sep 11;337:a1344.

Song Y, Chavarro JE, Cao Y, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr. 2013 Feb;143(2):189-96.

Sonoda T, Nagata Y, Mori M, et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci. 2004 Mar;95(3):238-42. 

Soumaoro LT, Iida S, Uetake H, et al. Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol. 2006 Oct 21;12(39):6355-60. 

Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: reduced develop­ment of castration-resistant disease and prostate cancer mortality. Eur Urol. 2013 Apr;63(4):709-16.

Srivastava SK, Xiao D, Lew KL, et al. Allyl isothiocyanate, a constituent of crucifer­ous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo. Carcinogenesis. 2003 Oct;24(10):1665-70.

St Sauver JL, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ. Protective as­sociation between nonsteroidal antiinflam­matory drug use and measures of benign prostatic hyperplasia. Am J Epidemiol. 2006 Oct 15;164(8):760-8.

Stangelberger A, Waldert M, Djavan B. Prostate cancer in elderly men. Rev Urol. 2008 Spring;10(2):111-9.

Stark A, Madar Z. Phytoestrogens: a review of recent findings. J Pediatr Endocrinol Metab. 2002 May;15(5):561-72. 

Steiner MS, Raghow S. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World J Urol. 2003 May;21(1):31-6. 

Stephan C, Stroebel G, Heinau M, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. Cancer. 2005 Sep 1;104(5):993-1003.

Stettner M, Kramer G, Strauss A, et al. Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Eur J Cancer Prev. 2012 Jan;21(1):55-64. 

Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Natl Cancer Inst. 1997 Jul 16;89(14):1006-14. 

Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color doppler ultrasonography (TRC­DUS) for assessment of angiogenesis in prostate cancer. Anticancer Res. 2001 Jul- Aug;21(4B):2907-13.

Strum SB, Pogliano D. A Primer on Prostate Cancer: An Empow­ered Patient’s Guide. Hollywood, FL: The Life Extension Founda­tion; 2005.

Subbarao K, Jala VR, Mathis S, et al. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75. 

Sundaram S, Ghosh J. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem BiophysRes Commun. 2006 Jan 6;339(1):93-8. 

Sundram V, Chauhan SC, Ebeling M, Jaggi M. Curcumin attenuates beta-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS One. 2012;7(4):e35368. 

Supabphol A, Supabphol R. Antimetastatic potential of N-acetylcysteine on human prostate cancer cells. J Med Assoc Thai. 2012 Dec;95 Suppl 12:S56-62. 

Sutcliffe S, Giovannucci E, Leitzmann MF, Rimm EB, Stampfer MJ, et al. A prospective cohort study of red wine consumption and risk of prostate cancer. Int J Cancer. 2007;120:1529-35. 

Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Differential apoptotic response of human cancer cells to organoselenium compounds. Cancer Chemother Pharmacol. 2010 Aug;66(3):475-84. 

Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A. Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer. 2008 Feb 12;98(3):636-40. 

Ta N, Walle T. Aromatase inhibition by bioavailable methylated flavones. J Steroid Biochem Mol Biol. 2007 Oct;107(1-2):127-9.

Taccone-Gallucci M, Manca-di-Villahermo­sa S, Battistini L, et al. N-3 PUFAs reduce oxidative stress in ESRD patients on main­tenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006 Apr;69(8):1450-4.

Taira AV, Merrick GS, Galbreath RW, et al. Performance of trans­perineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):71-7.

Takase Y, Levesque MH, Luu-The V, et al. Expression of enzymes involved in estrogen metabolism in human prostate. J Histochem Cytochem. 2006 Aug;54(8):911-21. 

Tan RS, Salazar JA. Risks of testosterone replacement therapy in ageing men. Expert Opin Drug Saf. 2004 Nov;3(6):599-606.

Tareen B, Summers JL, Jamison JM, et al. A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci. 2008;5(2):62-7. 

Tchetgen MB, Song JT, Strawderman M, Jacobsen SJ, Oesterling JE. Ejaculation increases the serum prostate-specific antigen concentration. Urology. 1996 Apr;47(4):511-6.

Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, Diederich M. Anti-proliferative potential of curcumin in androgendependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol. 2011 Mar;38 (3):603-11. 

Teiten MH, Gaascht F, Eifes S, Dicato M, Diederich M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr. 2010 Mar;5(1):61-74.

Teiten MH, Gaigneaux A, Chateauvieux S, et al. Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines. Omics. 2012 Jun;16(6):289-300. 

Tewari A, Divine G, Chang P, et al. Long-term survival in men with high grade prostate cancer: a comparison between conserva­tive treatment, radiation therapy and radical prostatectomy--a propensity scoring approach. J Urol. 2007 Mar;177(3):911-5.

Thakur VS, Gupta K, Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis. 2012 Feb;33(2):377-84.

Thirugnanam S, Xu L, Ramaswamy K, Gnanasekar M. Glycyr­rhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncol Rep. 2008 Dec;20(6):1387-92.

Thomas RJ, Williams MMA, Sharma H, et al. A double-blind, placebo RCT evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer: The U.K. National Cancer Research Network (NCRN) Pomi-T study. J Clin Oncol. 2013;31(suppl):abstract 5008. 

Thompson IM Jr, Goodman PJ, Tangen CM, et al. Long-term sur­vival of participants in the prostate cancer prevention trial. N Engl J Med. 2013 Aug 15;369(7):603-10.

Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17;349(3):215-24.

Tisman G and Strum SB. The Prostate Cancer Tools II (PCT II) Software Program as an Aid in Prostate Cancer Patient Counseling. PCR Insights. Published by Prostate Cancer Research Institute. Available at: http://www.prostate-cancer.org/PDFs/Is4-2.pdf. 2001 May; 4(2): 1-20.

Tombal B, Lecouvet F. Modern detection of prostate can­cer’s bone metastasis: Is the bone scan era over? Adv Urol. 2012;2012:893193.

Tomimoto A, Endo H, Sugiyama M, et al. Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Sci. 2008 Nov;99(11):2136-41.

Traka M, Gasper AV, Melchini A, et al. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008;3(7):e2568. 

Traka MH, Spinks CA, Doleman JF, et al. The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer. Mol Cancer. 2010;9:189. 

Trejo-Solis C, Pedraza-Chaverri J, Torres-Ramos M, et al. Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evid Based Complement Alternat Med. 2013;2013:705121. 

Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH. Curcumin blocks the activation of androgen and interlukin-6 on prostatespecific antigen expression in human prostatic carcinoma cells. J Androl. 2008 Nov-Dec;29(6):661-8. 

Tu WH, Thomas TZ, Masumori N, et al. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia. 2003 May-Jun;5(3):267-77.

Tuck SP, Hanusch B, Walker J, Datta HK. Prostate cancer and osteoporosis. Curr Osteoporos Rep. 2013 Mar;11(1):11-20.

Tunstall RG, Sharma RA, Perkins S, et al. Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. Eur J Cancer. 2006 Feb;42(3):415-21. 

UCCM. University of Cincinnati (UC) College of Medicine. Radiology. Prostate MRI Information: Hot It is Done. UC College of Medicine web page. Available at: http://www.med.uc.edu/radiology/research/prostateimaging/mriprocedure.aspx. Copyright © 2013. Accessed 10/25/2013.

UCF. Urology Care Foundation. Advanced Prostate Cancer. Available at: http://www.urologyhealth.org/urology/index.cfm?article=149. Last updated 3/2013. Accessed 10/29/2013.

UMMC. University of Maryland Medical Center. Gamma-linolenic acid. Available at: http://umm.edu/health/medical/altmed/supplement/gammalinolenic-acid. Last updated 6/24/2013a. Accessed 10/21/2013.

UMMC. University of Maryland Medical Center. Omega-6 fatty acids. Available at: http://umm.edu/health/medical/altmed/supplement/omega6-fatty-acids. Last updated 6/20/2013b. Accessed 10/18/2013.

UMMSM. University of Miami Leonard M. Miller School of Medicine. UM Researchers Present Dramatic Cancer Findings.  University of Miami Miller School of Medicine web page. Available at: http://www.med.miami.edu/news/view.asp?id=403. Accessed 10/21/2013.

UPMC. UPMC CancerCenter. Prostate Cancer. Transrectal Ultrasound. Available at: http://www.upmccancercenter.com/cancer/prostate/biopsyultrasound.cfm. 2013. Accessed 10/24/2013.

USDA. U.S. Department of Agricuture. Isoflavones contents of food. Taken from USDA Database: Sources of isoflavones. Available at: http://www.isoflavones.info/isoflavones-content.php. 2013. Accessed 10/21/2013.

USDC. U.S. Department of Commerce. United States Census Bureau. Age and Sex. Age and Sex Composition in the United States: 2011. Available at: http://www.census.gov/population/age/data/2011comp.html. Last updated 11/28/2012. Accessed 10/28/2013.

USPSTF. U.S. Preventive Services Task Force. Summaries for patients. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Available at: http://www.uspreventiveservicestaskforce.org/uspstf13/hiv/hivfinalrs.htm. (First published in Ann Intern Med, 2013;159(1)  [No authors listed]).

van den Bemd GJ, Chang GT. Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets. 2002 Feb;3(1):85-94.

Van Neste L, Herman JG, Otto G, Bigley JW, Epstein JI, Van Criekinge W. The epigenetic promise for prostate cancer diagnosis. Prostate. 2012 Aug 1;72(11):1248-61. 

Vayalil PK, Mittal A, Katiyar SK. Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF kappa B. Carcinogenesis. 2004;25:987-95. 

Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, Martin-Castillo B, Menendez JA. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat. 2011 Apr;126(2):355-64.

Venkateswaran, V, Klotz, LH, Fleshner, NE. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Cancer Res. 2002;62:2540-5. 

Vessella RL, Lange PH, Partin AW, et al. Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays. Urology. 2000 Jun;55(6):909-14.

Vicinanza R, Zhang Y, Henning SM, Heber D. Pomegranate juice metabolites, ellagic acid and urolithin A, synergistically inhibit androgen-independent prostate cancer cell growth via distinct effects on cell cycle control and apoptosis. Evid Based Complement Alternat Med. 2013;2013:247504. 

Vij U, Kumar A. Phyto-oestrogens and prostatic growth. Natl Med J India. 2004 Jan;17(1):22-6. 

von der Recke P, Hansen MA, Overgaard K. et al. The impact of degenerative conditions in the spine on bone mineral density and fracture risk prediction. Osteoporos Int. 1996;6:43–9.

von Holtz RL, Fink CS, Awad AB. Beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer. 1998;32(1):8-12.

Wang D, Dubois RN. Prostaglandins and cancer. Gut. 2006 Jan;55(1):115-22. 

Wang D, Wang H, Shi Q, et al. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep;6(3):285-95. 

Wang L, Ho J, Glackin C, Martins-Green M. Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol. 2012 Oct;5(5):344-55. 

Wang LQ. Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):289-309. 

Wang XL, Hur HG, Lee JH, Kim KT, Kim SI. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol. Jan 2005;71(1):214-9. 

Webber MM, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res. 1995 Oct;1(10):1089-94.

WebMD. Deep Vein Thrombosis Health Center. Doppler Ultrasound. Available at: http://www.webmd.com/dvt/doppler-ultrasound. Last updated 12/4/2010. Accessed 10/24/2013.

WebMD. FDA Rejects Green Tea Cancer Claims. 6/7/2005. Published on FOX NEWS web page. Available at: http://www.foxnews.com/story/2005/07/06/fda-rejects-green-tea-cancer-claims/. Accessed 10/18/2013.

WebMD. Find a Vitamin or Supplement. N-ACETYL CYSTEINE. Overview. Available at: http://www.webmd.com/vitamins-supplements/ingredientmono-1018-N-ACETYL%20CYSTEINE.aspx?activeIngredientId=1018&activeIngredientName=N-ACETYL%20CYSTEINE. Accessed 10/21/2013.

Webster J, Piscitelli G, Polli A, et al. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multi­centre study. Clin Endocrinol (Oxf). 1992 Dec;37(6):534-41.

Wen J, Zhao Y, Li J, et al. Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells. Prostate. 2013 Jul;73(10):1069-81.

Wertz K. Lycopene effects contributing to prostate health. Nutr Cancer. 2009;61(6):775-83. 

WHF. The world’s healthiest foods. Omega-3 fatty acids. Nutrient Rating Chart. Copyright © 2001-2013 The George Mateljan Foundation. Available at: http://www.whfoods.com/genpage.php?tname=nutrient&dbid=84#foodchart. Accessed 10/18/2013.

Williams CD, Whitley BM, Hoyo C, et al. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res. 2011 Jan 31(1):1-8.

Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000 Dec;3(4A):459-72. 

Wright JL, Stanford JL. Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control. 2009 Nov;20(9):1617-22.

Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med. 2003 May;3(2):107-12.

Xiao D, Srivastava SK, Lew KL, et al. Allyl isothiocyanate, a constituent of crucifer­ous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carci­nogenesis. 2003 May;24(5):891-7.

Xing N, Chen Y, Mitchell SH, Young CY. Quercetin inhibits the expression and function of the androgen receptor in LN­CaP prostate cancer cells. Carcinogenesis. 2001 Mar;22(3):409-14.

Xu S, Gao JP, Zhou WQ. Cyclooxygenase-2 and cyclooxygenase-2 inhibitors in pros­tate cancer. Zhonghua Nan Ke Xue. 2008 Nov;14(11):1031-4.

Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr. 2009 Apr;89(4):1155-63.

Yang GS, Chen ZD. Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma. Zhonghua Wai Ke Za Zhi. 2004 Sep 22;42(18):1111-5. 

Yang L, Zhang LY, Chen WW, et al. Inhibition of the expression of prostate specific antigen by curcumin. Yao Xue Xue Bao. 2005 Sep;40(9):800-3. 

Yang P, Cartwright C, Chan D, Vijjeswar­apu M, Ding J, Newman RA. Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Cancer Biol Ther. 2007 6(2):228-36.

Yang Y, Ikezoe T, Zheng Z, Taguchi H, Koeffler HP, Zhu WG. Saw Palmetto induces growth arrest and apoptosis of androgen-depen­dent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling. Int J Oncol. 2007 Sep;31(3):593-600.

Yavuz BB, Ozkayar N, Halil M, et al. Free testosterone levels and implications on clinical outcomes in elderly men. Aging Clin Exp Res. 2008 Jun;20(3):201-6

Ye YN, Liu ES, Shin VY, Wu WK, Cho CH. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. Toxicology. 2004 Oct 15;203(1-3):179-88. 

Yokota T, Matsuzaki Y, Koyama M, et al. Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007 Sep;98(9):1447-53. 

Yoo J, Lee YJ. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Mol Pharmacol. 2007 Dec;72(6):1586-92.

Yoshimura R, Matsuyama M, Mitsuhashi M, et al. Relationship between lipoxygenase and human testicular cancer. Int J Mol Med. 2004 Mar;13(3):389-93. 

Yousef FM, Jacobs ET, Kang PT, et al. Vitamin D status and breast cancer in Saudi Arabian women: case-control study. Am J Clin Nutr. 2013 Jul;98(1):105-10. 

Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006 34(1-2):109-15. 

Yu C, Gong AY, Chen D, Solelo Leon D, Young CY, Chen XM. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF. Mol Nutr Food Res. 2013. 

Yu W, Park SK, Jia L, et al. RRR-gamma-tocopherol induces human breast cancer cells to undergo apoptosis via death receptor 5 (DR5)-mediated apoptotic signaling. Cancer Lett. 2008 Feb 8;259(2):165-76.

Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H. Suppression of the androgen receptor function by quercetin through proteinprotein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem. 2010 Jun;339(1- 2):253-62. 

Zaichick V, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol. 1997;29(5):565-74. 

Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol. 2007 Oct;31(4):959-67.

Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep. 2008 Jun;35(2):107-17. 

Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neopla­sia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila Pa). 2008 Oct;1(5):369-75.

Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acidand phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 1999 Mar;20(3):445-51. 

Zhang J, Hsu BAJ, Kinseth BAM, Bjeldanes LF, Firestone GL. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer. 2003 Dec 1;98(11):2511- 20. 

Zhang L, Zhang WP, Hu H, et al. Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology. 2006 Apr;26(2):99-106. 

Zhang Z-F, Winton MI, Rainey C, et al. Boron is associated with decreased risk of human prostate cancer. FASEB J. 2001;15:A1089. 

Zhi H, Zhang J, Hu G, et al. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer. 2003 Sep 1;106(3):327-33. 

Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phyto- chemicals inhibit the growth of trans-plantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr. 1999 Sep;129(9):1628-35. 

Zi X, Agarwal R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci USA. 1999 Jun 22;96(13):7490-5.